Hamilton Lane (HLNE): The private markets gatekeeper now trading at a five-year low (2026)

Hamilton Lane Incorporated (NASDAQ: HLNE), an alternative asset manager focused entirely on private markets, currently trades at $90.32 — down 44% from its 52-week high of $179.19, and at a trailing P/E of 15.26x, the lowest in five years. 1 The selloff is tied directly to a short-seller report published in late April 2026. The underlying financials, however, tell a different story: three consecutive fiscal years of return on equity above 30%, free cash flow that grew 45% in FY2026, and a fee revenue business that expanded its margin to 50%.

Whether the gap between the business and the stock is an opportunity or a warning depends almost entirely on how you read one question: did Hamilton Lane change its accounting definitions to manufacture earnings growth, or is the growth real?

What the company actually does

Hamilton Lane is not a fund. It is the organization that helps institutional investors — pension funds, sovereign wealth funds, endowments, insurance companies — decide which private equity, private credit, infrastructure, and real assets funds to allocate to, and then manages those allocations on their behalf.

The business runs on two parallel revenue streams. The first is advisory and management fees: clients pay Hamilton Lane to give them access to its 30-plus years of private markets data, its deal-sourcing network, and its fund selection process. This side of the business manages or advises on roughly $1 trillion in client assets (AUM of $141.8 billion plus assets under advisement of $905.3 billion as of March 2026). 2

The second is its fast-growing Evergreen platform — a set of perpetual (non-drawdown) investment vehicles that allow individual investors and smaller institutions to participate in private markets without committing to the typical 10-year locked-up fund structure. Evergreen AUM reached $17.5 billion by March 2026, up 64% year-over-year.2

Its closest direct competitor is StepStone Group (STEP), which offers a similar combination of private markets advisory, fund-of-funds management, and data services. The mega-cap alternative managers — Blackstone (BX), KKR, Apollo (APO), Ares (ARES) — occupy the same capital ecosystem but operate primarily as general partners who raise and invest their own flagship funds, not as advisors and fund-of-funds managers for other investors' capital.

ROE: three years above 30%

The channel's first hard screen is trailing three-year return on equity above 15%, sustained every year. Hamilton Lane clears the bar by a significant margin. 3

Loading chart…

FY2026 ROE came in at 32.44%, FY2025 at 39.22%, and FY2024 at 36.35% — the lowest of the three was still more than double the 15% threshold. 3 Among the seven alternative asset managers in the peer set, only Blackstone (29.53%) comes within 10 percentage points of HLNE's FY2026 ROE; KKR sits at 7.66%, Ares at 14.18%, Apollo at 8.49%. 4

The TTM ROE has since dipped to 27.77%, reflecting the share-count dilution discussed below — but it remains well above the threshold.

Free cash flow: five consecutive positive years

FCF is defined here as operating cash flow minus capital expenditures. Hamilton Lane has been FCF-positive every year for at least five fiscal years. 5

Loading chart…

FY2026 FCF was $419 million (operating cash flow $424.9M minus CapEx $5.8M), up 45% from $288.7M in FY2025. 5 FCF yield against the current market cap sits at 8.26%, a five-year high. The one meaningful deviation in the sequence was FY2024, when FCF dropped to $109.8M — a 50% fall; no single confirmed cause has been publicly disclosed, though operating cash flow recovered sharply in FY2025 and FY2026. 6

At $90.32 per share, the P/FCF ratio is 12.1x — compared to its five-year average of 21.4x. 1

Revenue and earnings

FY2026 revenue was $758.99 million, a 6.5% increase year-over-year and a five-year compound annual growth rate of roughly 19.8% from $367.9M in FY2022. 7 The deceleration in FY2026 revenue growth is partly explained by retro fees (one-time performance fee adjustments from prior periods): those fell from approximately $21 million in FY2025 to $3 million in FY2026. Management and advisory fees — the core recurring revenue line — grew 14% year-over-year to $584 million. 8

Net income for FY2026 was $249.2 million, up 14.6% from $217.4M in FY2025, producing GAAP diluted EPS of $5.92. 7

Loading chart…

Operating margin has compressed slightly over the period — from 46.1% in FY2022 to 42.8% in FY2026 — while net margin has recovered from a trough of 20.6% in FY2023 back to 32.8% in FY2026. 7 The FY2023 net margin dip was tied to a significant drop in incentive fees (carried interest realizations), not to operating deterioration.

At the fee-related earnings (FRE) level — the metric Hamilton Lane uses to track recurring profitability, stripping out incentive fees and certain equity compensation — FRE rose 25% to $345 million in FY2026, with an FRE margin of 50%, up from 48% the prior year. 2 Note: the FRE definition itself is contested — see the Risk section.

Balance sheet

Hamilton Lane's balance sheet is conservative relative to its earnings power. 9

Total debt: $356.5M (long-term debt $278.4M + capitalized leases $78.1M)
Cash and equivalents: $363.9M — essentially flat against total debt (net cash position of approximately $7.4M)
Debt/equity ratio: 0.24
Debt/EBITDA: 1.07x
Interest coverage: 21.73x
Current ratio: 2.88 (current assets $561.3M / current liabilities $195.0M)
Altman Z-Score: 5.64, well above the 3.0 safety threshold

CFO Jeff Armbrister described the company as "modestly levered" on the Q4 FY2026 earnings call and noted the company would continue evaluating use of its balance sheet for growth. 8 The largest asset on the balance sheet is long-term investments of $1.3 billion, which consists primarily of co-investment positions alongside client funds — these are illiquid but mark-to-market each quarter.

Valuation vs. peers and historical range

At $90.32 per share, every major valuation multiple is at or near a five-year low. 1

Metric	Current	5-year avg	Discount
P/E (trailing)	15.26x	23.46x	−35%
P/B	4.31x	7.45x	−42%
P/FCF	12.10x	21.39x	−43%
EV/EBITDA	15.13x	17.55x	−14%

Against seven alternative asset management peers, HLNE trades at the lowest trailing P/E and P/B while delivering the highest ROE: 4

Ticker	Company	Mkt cap	P/E (TTM)	P/B	EV/EBITDA	ROE	FCF yield
HLNE	Hamilton Lane	$5.1B	15.26x	4.31x	15.13x	32.44%	8.26%
BX	Blackstone	$145.8B	30.41x	11.12x	n/a	29.53%	3.04%
KKR	KKR & Co.	$84.4B	32.72x	2.99x	n/a	7.66%	−0.58%
APO	Apollo Global Mgmt	$74.1B	81.35x†	3.99x	n/a	8.49%	10.60%
ARES	Ares Management	$41.0B	57.83x	10.93x	38.95x	14.18%	3.93%
OWL	Blue Owl Capital	$15.7B	84.33x	3.24x	15.94x	5.70%	8.18%
TPG	TPG Inc.	$16.0B	117.61x†	5.89x	n/a	10.76%	6.08%
STEP	StepStone Group	$6.5B	n/a‡	7.32x	n/a	n/a‡	n/a

† APO and TPG trailing P/E are distorted by GAAP accounting complexity; forward P/E (APO 13.52x, TPG 14.12x) is more meaningful for those names. ‡ STEP TTM figures are unusable due to a large one-time impairment charge. 10 11 12 13 14 15

The core tension the table illustrates: the highest-ROE name in the set is also the cheapest on most valuation multiples — and the only one with a 44% drawdown over the past year. Both of those things being true simultaneously is the central question for any investor looking at this stock.

Competitive moat

Hamilton Lane's moat rests on two quantifiable pillars.

Client retention above 95%. 16 When a pension fund or endowment builds a private markets portfolio through Hamilton Lane, the firm's team and systems become embedded in that institution's investment process. Custom separate accounts reflect years of portfolio construction. Switching to a competitor means abandoning that portfolio history. The retention rate — consistently above 95% by third-party estimates — is the measurable outcome of that stickiness.

Proprietary data covering 64,070+ funds and 164,490+ portfolio companies across 57 vintage years. 17 No newly launched competitor can replicate three decades of private market performance data. This database underpins Hamilton Lane's fund selection, co-investment sourcing, and secondary market deal evaluation — and feeds directly into its Cobalt platform, a data and analytics product sold separately to institutional clients.

The business does have structural limits. Unlike Apollo (with its Athene insurance platform) or Blue Owl (with its business development companies), Hamilton Lane lacks a large permanent capital vehicle that generates fee income regardless of fundraising cycles. Its Evergreen platform is the closest analog, but it still depends on net inflows to grow fee-earning assets. That's an important distinction if retail investor appetite for private markets reverses.

Risk factors

The Hunterbrook short report

On April 27, 2026, Hunterbrook Media published an investigative report titled Inside Hamilton Lane's Pandora's Box, co-authored by Bethany McLean (a journalist who helped expose Enron). Hunterbrook Capital simultaneously disclosed a short position in HLNE. 18 The stock fell 5.67% that day to $89.46.

The report's two core allegations:

Day-one markups. When Hamilton Lane purchases secondary private equity positions at a discount to net asset value, it immediately marks them back up to the previous valuation. The report estimated that roughly one-third of the appreciation in Hamilton Lane's Private Assets Fund (PAF) came from this accounting step rather than from underlying asset performance.
FRE definition change. In 2025, Hamilton Lane changed how it calculates fee-related earnings (FRE): it added fee-related performance revenue (FRPR, earned on unrealized NAV increases rather than actual realizations) and removed equity compensation from the cost base. Hunterbrook calculated that under the old definition, FRE would have declined 16% rather than grown 37% over the nine months when the change was active. 18

Cliffwater CIO Blake Nesbitt — a member of a Securities and Exchange Commission advisory panel — called the combination of evergreen fund fee structures and day-one markups "very dangerous" and said it was unprecedented in private markets history. 18

Hamilton Lane's Co-CEO Erik Hirsch responded at length on the Q4 FY2026 earnings call. He said approximately 70% of the company's secondary market returns come from post-purchase appreciation of underlying assets, with roughly 30% attributable to purchase structuring and discount capture. He described the day-one markup accounting as consistent with all industry peers and compliant with GAAP. He also noted that in FY2026 the firm declined 99% of the secondary deal flow it reviewed by dollar volume — a claim he framed as evidence of pricing discipline rather than cherry-picking. 8

The short report remains the primary overhang on the stock. No independent regulatory action has been reported, and no major audit firm commentary on the accounting practices has been made public. As of the available evidence, this is a dispute between a short-seller and management — not a confirmed regulatory finding.

Additional risks

Short interest at 10.65% of float. Short positions in HLNE have risen from 3.57 million shares to 4.0 million over the past month, with days-to-cover of 4.51. 1 This is elevated for a stock this size and reflects ongoing market skepticism about the accounting dispute.

GPA fund outflows. Hamilton Lane's Global Private Assets Fund (GPA) recorded net outflows of approximately $172 million in March 2026 — the largest single-month net outflow in the fund's public data history, and nearly nine times larger than its previous outflow episode in September 2025. 18 Management attributed the outflows to industry-wide redemption pressure from large institutions rebalancing, rather than Hamilton Lane-specific concerns.

Share dilution. The share count grew 35.1% year-over-year, from approximately 41.5 million to 56.1 million shares. 1 This dilution reflects equity compensation awards (including 544,000 restricted shares each granted to the two Co-CEOs in 2025, valued at approximately $71 million per person at grant) and acquisition-related share issuance. The company's $100 million buyback authorization, of which roughly $80 million remained as of the Q4 earnings call, covers only about 1.4% of the current market cap.

FRPR concentration. Fee-related performance revenue — the contested component — totaled $77.7 million in FY2026, representing 22.5% of FRE. If NAV appreciation in the Evergreen funds were to stall or reverse, this revenue line would fall sharply. 2

Regulatory risk. Several of Hamilton Lane's Evergreen funds are registered investment companies under the Investment Company Act, subject to restrictions on leverage, related-party transactions, and governance. The Financial Accounting Standards Board (FASB) has received formal requests to revisit the "practical expedient" accounting guidance that underlies some of HLNE's valuation practices. Any FASB rule change could require restatement or create reporting discontinuities. 19

Near-term catalysts and market context

Next earnings: Q1 FY2027 results are expected on or around August 4, 2026. That quarter will be the first to show whether April's management guidance of $265+ million in net inflows across Evergreen products materialized, and whether March's GPA outflow was a one-time event or the start of a trend. 20

52-week range: $179.19 (52-week high) to approximately $87 (52-week low); the current price of $90.32 sits near the bottom of that range. The stock trades 27% below its 200-day moving average of approximately $123.58. 1

Dividend: $0.60 per share per quarter ($2.40 annualized), yielding 2.66% at the current price. This represents the ninth consecutive year of double-digit annual dividend growth. 2 The 36.5% payout ratio leaves ample room for future increases even if earnings temporarily compress.

Analyst consensus: Seven analysts cover the stock. 21 The consensus is Buy, with an average target price of approximately $136 (roughly 50% above the current price of $90.32 — the analyst target price range is subject to systematic optimism bias, and the $102-$179 spread reflects genuine disagreement about the accounting controversy rather than normal price dispersion). Specific post-Q4 moves: Goldman Sachs raised its target to $148 (Buy maintained), Oppenheimer raised to $179 (Outperform), JPMorgan lowered to $148 (Overweight maintained), and BMO Capital lowered to $102. 21

Insider buying signal. Over the past six months, five HLNE insiders — including Co-CEO Erik Hirsch, Co-CEO Juan Delgado-Moreira, Executive Co-Chairman Mario Giannini, director David Berkman, and COO Andrea Kramer — made a combined six open-market purchases totaling approximately $4.2 million, with zero sales. 22 Insiders hold 4.74% of total shares outstanding. This is a notable signal against the short thesis, though the context matters: those same insiders received large equity grants in 2025 and have a strong incentive to defend the stock price.

Upcoming fund milestones: The sixth Direct Equity Opportunities Fund is expected to close at approximately $2.8 billion (35% larger than the prior vintage); 8 the seventh Secondary Fund and first GP-led Secondary Fund are in active fundraising; and a new Credit Income Fund (the twelfth Evergreen product) launched in April 2026 with $325 million in seed capital.

What to watch

The Q1 FY2027 report in August is the most direct near-term test. Three things to check: (1) whether Evergreen net inflows across all products returned to strongly positive in April, May, and June as management guided; (2) whether the GPA fund's March outflow was isolated or continued; and (3) whether FASB issues any formal comment on private markets valuation practices. If inflows hold and no regulatory action emerges, the Hunterbrook thesis looks increasingly like a short-seller overreach. If GPA outflows widen or FASB responds formally, the valuation discount the market is applying today may be justified.

Hamilton Lane arrives at this juncture with a debt-to-equity ratio of 0.24, a nine-year dividend growth streak, and fee-related revenue that grew 20% in FY2026. The accounting dispute is real and material — but it has not been confirmed by any regulator or independent auditor.

Current stock price as of May 22, 2026: $90.32. This article is for informational purposes only and does not constitute investment advice.